DIRECTOR DEALINGS: Dechra Pharmaceuticals Executive Exercises Options
LONDON (Alliance News) - Dechra Pharmaceuticals PLC Wednesday said company secretary Zoe Goulding exercised options over 958 shares pursuant to the SAYE Scheme at an exercise price of GBP3.7564 each. Following the transaction, Goulding's interest is 12,891 shares or 0.015% of the current is Read More